Real world AI in neurosciences for the benefit of doctors and patients
11/5/22, 11:05 AM - 11/5/22, 11:35 AM (Europe/Amsterdam) (30 minutes)

Stephane Doyen, PhD
Chief Data Scientist & Technology Officer, Co-Founder Omniscient Neurotechnology, Sydney
Chief Data Scientist & Technology Officer, Co-Founder Omniscient Neurotechnology, Sydney

A continual innovator, Dr. Stephane Doyen, PhD. MBA, bridges the gap between science and entrepreneurism. With a PhD in Neurosciences and over 30 publications and 45 patents covering topics from machine learning on brain scans to software engineering, Dr. Doyen co-founded a a multi award winning (SXSW 2022, MICCAI 2022) brain-mapping company, Omniscient Neurotechnology, to help doctors delivering enhanced brain. Dr. Doyen is passionate about growing and supporting the organization as Chief Data Scientist and Technology Officer while also remaining hands on, having coded Omniscient’s core algorithms: the Structural Connectivity Atlas and brain patterns detectors for functional brain scans. Prior to his entrepreneurial venture, he led the delivery of enterprise-grade multi-million analytics-based solutions for Fortune 500 organizations as Director of Data Science and AI for Oliver Wyman Labs in Asia and Pacific.


In the past decade, we have seen a myriad of fascinating and relevant machine learning and advanced analytics projects for healthcare coming both form the academia and the big tech industry surfacing on media channels and in specialised journals. Those projects bear the promise of a radical shift in medical practice, enabling for instance, less biased diagnostics encompassing an even larger amount of data sources, or truely personalised treatments. In addition to this, they’re often architected to function on commodity devices (e.g., phones, cloud) enabling wider access to the device and empowerment of patients. However it is too rarely that we see those promising endeavour making their way to the doctor’s office or in the patient’s hands creating a substantial missed opportunity. One can entertain the view that if healthcare could benefit directly from the pioneering machine learning tools available in labs, private or public, the healthcare system would leap ahead by at least 5 to 10 years. Yet this tsunami of new AI powered tools remains to be seen in the field. In this presentation, I will outline through projects recently carried out in the field of brain mapping for Neurosurgery and MRI mining for Mental Health, some of the key enablers for real world AI for patient care (as opposed as in the lab proof of concept), explain some of the pitfalls as well as limitations often encountered, and discuss perspectives and useful frameworks to consider patient safety and technological progress.